Schizoaffective Disorders Completed Phase 4 Trials for Telmisartan (DB00966)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00981526Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With SchizophreniaTreatment